A comprehensive approach to immunophenotyping for targeted drug discovery and development

Download the Digital Article

With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies.

Download this content-rich digital article to read about considerations for implementing and standardising high-dimensional immune profiling methods into drug development programs. Learn about different applications that demonstrate the robustness and reproducibility of a mass cytometry-based analysis to deeply interrogate complex biological systems in drug development strategies, including:

  • Rigorous testing of promising drug targets for safety and efficacy
  • Correlates of survival prediction to support new treatment strategies
  • Using systems biology for thorough target evaluation
  • Enabling comprehensive and quantitative analysis in all phases of drug development

Related Articles